A cancer diagnosis is terrifying, and treatment choices are complex, with profound impacts on finances and quality of life. There are usually several treatment options presented to patients, depending on the patient’s age, other medical conditions, and the severity of the disease. All treatments are associated with their benefits and tradeoffs. As a result, […]
October is breast cancer awareness month. This month more than 22,000 people in the U.S. will receive a breast cancer diagnosis. Breast cancer is the second most diagnosed cancer in American women, yet many still have misconceptions about the disease. Let’s separate some common myths from facts.
October is breast cancer awareness month. About one in eight women will develop breast cancer during her life. Breast cancer is one of the most commonly diagnosed cancers in American women, second only to skin cancer, but it can also affect men. This month, nearly 22,000 people in the U.S. will receive a breast cancer […]
Comorbidity can be summed up in a simple question: “In addition to cancer, what else is wrong with you?” A comorbidity is an existing and unrelated diagnosis at the time of a cancer diagnosis. Common comorbidities include heart disease, diabetes, hypertension, and obesity.
Shared decision-making and value-based care are emerging approaches to obtaining additional value from patient care. Shared decision-making is the process of interacting with patients who wish to be involved in arriving at an informed, values-based choice among two or more medically reasonable alternatives.
The LIVESTRONG Cancer Institutes of the Dell Medical School to Present at Clinical Congress 2019 Title of the panel: Reading Between the (Guide)-Lines: Can Real-World Survival Data Identify Patients Whose Survival Isn’t Improved by Guidelines-Based Treatments?